Literature DB >> 1457341

Differential expression of cAMP-kinase subunits is correlated with growth in rat mammary carcinomas and uterus.

G Houge1, Y S Cho-Chung, S O Døskeland.   

Abstract

The expression of the regulatory (RI and RII) and catalytic (C) subunits of cAMP-dependent protein kinase was found to depend on the growth-state in oestrogen-dependent DMBA-induced mammary adenocarcinomas as well as in uteri of the rat. Castration-induced atrophy of the oestrogen-dependent tissues was accompanied by a decrease of the concentration of regulatory subunits (RI and RII) relative to both the catalytic subunit (C) and total protein, decreasing the R/protein and R/C ratios. A hyperplastic burst caused by high-dose oestrogen-replacement treatment was associated with an increased level of RI and little change in RII and C levels. Only minor differences were noted for the expression of mRNA for the alpha and beta subtypes of RI, RII and C between rat uteri from castrated and oestrogen-treated animals, or between mammary tumours from normal and castrated animals. Expression of RI beta-mRNA was detected only in the uterus. Our findings provide an experimental correlate for the reported value of the parameter R/protein in human mammary cancer biopsies to predict prognosis and outcome of therapy. Due to the sensitivity of the R/protein ratio towards changes in extracellular protein content, we recommend the biologically more meaningful R/C ratio in further clinical evaluations of mammary tumour biopsies.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1457341      PMCID: PMC1978049          DOI: 10.1038/bjc.1992.404

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  53 in total

1.  Intracellular cAMP levels in normal rat mammary gland and adenocarcinoma. In vivo vs in vitro.

Authors:  L A Cohen; P C Chan
Journal:  Life Sci       Date:  1975-01-01       Impact factor: 5.037

2.  The tissue-specific extinguisher locus TSE1 encodes a regulatory subunit of cAMP-dependent protein kinase.

Authors:  M Boshart; F Weih; M Nichols; G Schütz
Journal:  Cell       Date:  1991-09-06       Impact factor: 41.582

3.  cAMP mediated proteolysis of the catalytic subunit of cAMP-dependent protein kinase.

Authors:  B A Hemmings
Journal:  FEBS Lett       Date:  1986-02-03       Impact factor: 4.124

Review 4.  Protein serine/threonine kinases.

Authors:  A M Edelman; D K Blumenthal; E G Krebs
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

5.  Cyclic nucleotide levels in human breast cancer and in rat mammary tissues during tumor development.

Authors:  E Israeli; B Raz; H Kerner; D Barzilai
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

6.  Stimulatory and inhibitory effects of estrogen on uterine DNA synthesis.

Authors:  F Stormshak; R Leake; N Wertz; J Gorski
Journal:  Endocrinology       Date:  1976-12       Impact factor: 4.736

7.  Subtractive hybridization cloning of a tissue-specific extinguisher: TSE1 encodes a regulatory subunit of protein kinase A.

Authors:  K W Jones; M H Shapero; M Chevrette; R E Fournier
Journal:  Cell       Date:  1991-09-06       Impact factor: 41.582

8.  The amounts of rat liver cyclic AMP-dependent protein kinase I and II are differentially regulated by diet.

Authors:  R Ekanger; O K Vintermyr; S O Døskeland
Journal:  Biochem J       Date:  1988-12-01       Impact factor: 3.857

Review 9.  Validity of the DMBA-induced mammary cancer model for the study of human breast cancer.

Authors:  E Escrich
Journal:  Int J Biol Markers       Date:  1987 Sep-Dec       Impact factor: 3.248

10.  Cyclic AMP binding proteins and prognosis in breast cancer.

Authors:  W R Miller; R A Elton; J M Dixon; U Chetty; D M Watson
Journal:  Br J Cancer       Date:  1990-02       Impact factor: 7.640

View more
  1 in total

1.  8-Chloro-cAMP induces apoptotic cell death in a human mammary carcinoma cell (MCF-7) line.

Authors:  R Bøe; B T Gjertsen; S O Døskeland; O K Vintermyr
Journal:  Br J Cancer       Date:  1995-11       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.